Midterm follow-up after pharmacomechanical thrombolysis for lower extremity deep venous thrombosis.
OBJECTIVE
To provide follow-up in patients treated with pharmacomechanical thrombolysis (PhMT) for lower extremity deep venous thrombosis (DVT).


METHODS
Retrospective analysis of prospectively collected data. Patients underwent clinical evaluation, duplex ultrasound, venous clinical severity scoring, venous segmental disease scoring, and venous disability scoring.


RESULTS
Fourteen patients were available for evaluation. Median age was 40 years (19-58). Median follow-up was 24 months (13-69 months). Thirteen of 14 patients (93%) had a venous disability score < 1 and 13 of 14 patients (93%) had a venous clinical severity scoring < 5. In all but 1 patient the venous segmental disease scoring score was < 5. All iliac segments were patent, all but 3 patients had partial infrainguinal obstruction and 5 of 14 (36%) had reflux.


CONCLUSIONS
Our data demonstrate that the good early clinical results after PhMT can be sustained on longer follow-up and may prevent the development of advanced postthrombotic syndrome.
Gasparis
Antonios P
AP
Stony Brook University Medical Center, Surgery, Stony Brook, New York, USA. antonios.gasparis@stonybrook.edu
Labropoulos
Nicos
N
Tassiopoulos
Apostolos K
AK
Phillips
Brett
B
Pagan
Jose
J
Cheng Lo
Ricotta
John
J
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004185:Disability Evaluation; D005260:Female; D006801:Humans; D035002:Lower Extremity / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D010690:Phlebography; D054070:Postthrombotic Syndrome / Q000209:etiology / Q000517:prevention & control*; D012189:Retrospective Studies; D012720:Severity of Illness Index; D017131:Thrombectomy; D015912:Thrombolytic Therapy; D013997:Time Factors; D016896:Treatment Outcome; D018615:Ultrasonography, Doppler, Color; D014654:Vascular Patency; D020246:Venous Thrombosis / Q000150:complications / Q000473:pathology / Q000628:therapy*; D055815:Young Adult
D000925:Anticoagulants